Regional Audit and Feedback Intervention to Improve Quality of Care in Ovarian Cancer Treatment: The Easy-Net Experience

View at publisher
Authors: Elisa Piovano, Annamaria Ferrero, Giovannino Ciccone, Marco Camanni, Anna Castiglione, Manuela Ceccarelli, Luca Fuso, Maria Elena Laudani, Vitor Hugo Martins, Riccardo Ponzone, Andrea Puppo, Andrea Scoletta
+53 more Daniela Surico, Paolo Zola, Eva Pagano, the Piemonte Ovarian Cancer Audit Group, Maggiorino Barbero, Patrizia Bergese Bogliolo, Carlo Bocci, Piero Grassano, Gianmauro Numico, Stefano Prigione, Fabrizio Bogliatto, Maurizio Brusati, Elena Maria Delpiano, V Distratis, Raffaella Enria, Veronica Galis, G. Gorzegno, Guido Menato, Paola Modaffari, Gabriele Molina, Enrico Panuccio, Elisa Tripodi, Arianna Vitale, Francesco Marocco, Valentina Tuninetti, Marco Vaira, Giorgio Valabrega, Saverio Danese, Dionyssios Katsaros, Davide Marenco, Marco Mitidieri, Paola Ballario, Alberto Daniele, Marinella Destefanis, Gianna Di Costanzo, Maria Teresa Giachino Amistà, Elena Olearo, Azzurra Ottone, Silvia Parisi, Elisa Peano, Alice Peroglio Carus, Manuela Rosso, Alberto Arnulfo, Riccardo Fiorentino, Davide Gallina, Giuliana Leonardi, Elisa Perfetti, Giovanni Ruspa, Alessandro Vigone, Laura Zavallone, Oscar Bertetto, Marinella Mistrangelo, Eugenio Volpi
Cited by: 0
References: 14

Abstract

PURPOSE: In 2009, a regional audit on ovarian cancer in the Regional Cancer Care Network (RCCN) of Piemonte (Italy) documented that patients were widely distributed across different treatment centers, with evidence of suboptimal care. We present the re-audit and feedback (A&F) intervention performed in 2016-2020 and the variation on quality of care and outcomes. METHODS: An A&F intervention was implemented across gynecologic units treating ovarian cancer in Piemonte. Key recommendations and indicators were identified from international guidelines. Global adherence to guideline recommendations was measured as the mean percentage of adherence across all the indicators. Data were collected retrospectively (May-December 2016, baseline period) and prospectively (May 2017-September 2020). Change in adherence to recommendations over time was monitored and feedback provided during quarterly meetings. Overall survival was identified as clinical outcome. RESULTS: Among 1,030 women (77% advanced stage), the global adherence to guidelines increased by 2.1% (95% CI, 1.6 to 2.6) every 6 months, from 51.3% to 70.4%. The likelihood of treatment in high-volume surgical centers and multidisciplinary team discussions before treatment increased over time (odds ratio [OR], 1.15 [95% CI, 1.08 to 1.21] and OR, 1.21 [95% CI, 1.15 to 1.28]). Five-year survival was 47% overall (87% among early and 35% among advanced stages). Although no consistent trend in survival was observed during the A&F period, a 10% increase in global adherence was associated with improved 5-year survival (hazard ratio, 0.91 [95% CI, 0.87 to 0.95]). CONCLUSION: The implementation of this A&F initiative was associated with improvements in quality-of-care indicators for ovarian cancer, highlighting the potential value of A&F methodologies to support quality improvement activities.

Fields of Study & Subjects

Ovarian cancer diagnosis and treatment Clinical practice guidelines implementation Health Policy Implementation Science

Publication details

Journal / source
JCO Oncology Practice
Pages
OP2500309–OP2500309
Publication date
29 January 2026
Language
EN